3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Recurrence
2
Lymphoma, Follicular
2
Lymphoma, B-Cell, Marginal Zone
2
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Lymphoma, Non-Hodgkin
1
Lymphoma, Mantle-Cell
1
Lymphoma, B-Cell
1
Leukemia, Myeloid, Acute
1
Interventions
enfortumab vedotin
4
pembrolizumab
2
Gemcitabine
2
Cisplatin
2
vinflunine
1
ulixertinib
1
trastuzumab biosimilar HLX02
1
trametinib
1
sapanisertib
1
sacituzumab govitecan
1
relatlimab
1
pertuzumab
1
palbociclib
1
osimertinib
1
omipalisib
1
larotrectinib
1
ipatasertib
1
erdafitinib
1
durvalumab
1
defactinib
1
dabrafenib
1
copanlisib
1
capivasertib
1
binimetinib
1
avelumab
1
adavosertib
1
X-Rays
1
Trastuzumab
1
Surgical Procedures, Operative
1
Sunitinib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has announcements
×
Urinary Bladder Neoplasms
×
fludarabine
×
Clear all
No trials found.